Following U.S. Stocks are among the “Most Active” Stocks in the course of recent trading session, Friday: Facebook Inc (NASDAQ:FB), Banco Santander, S.A. (ADR) (NYSE:SAN), Biogen Idec Inc (NASDAQ:BIIB), Transocean LTD (NYSE:RIG)

• Banco Santander, S.A. (ADR) (NYSE:SAN), with shares raised 6.11% is now trading at $7.30. The Stock is active as 6.21M shares changed hands versus its average volume of 6.71M shares.

• Biogen Idec Inc (NASDAQ:BIIB), with shares climbed 7.41% is now trading at $465.67, hitting new 52-week high of $480.18. The Stock is active as 5.33M shares changed hands versus its average volume of 1.46M shares.

• Facebook Inc (NASDAQ:FB) with shares picked up 2.08% is now trading at $84.44, hitting new 52-week high of $84.54. The Stock is active as 21.82M shares changed hands versus its average volume of 24.13M shares.

• Transocean LTD (NYSE:RIG) with shares rose 4.94% is now trading at $14.86. The Stock is active as 6.01M shares changed hands versus its average volume of 11.93M shares.

Latest NEWS regarding these Stocks are depicted underneath:

Banco Santander, S.A. (NYSE:SAN)

Formerly on March 12, Banco Santander, S.A. (SAN), declared the launch of its I LOVE MY BANK initiative. The innovative colleague engagement and customer service program is part of the Bank’s broader 2015 effort to strengthen its connection to its customers and colleagues – its two most important constituencies – through investing resources into enhancing those relationships.

The initiative will harness the power of the Bank’s most important assets by transforming colleagues into brand advocates through the I LOVE MY BANK car program, which offers eligible employees the chance to sign up for a subsidized lease on a branded 2015 FIAT® 500 Sport HB.

As part of the I LOVE MY BANK initiative, Santander is forging a deeper connection with its customers through an in-branch listening tour across its Northeast footprint in New England, New York, New Jersey and Pennsylvania. Now through March 27, 2015, Santander is hitting the road in the branded FIAT® 500 to engage with customers to solicit feedback on their experience with the Bank. This will give Santander a stronger understanding of how it can be a better bank, and determine what tools and resources it should have in place to assist its customers make progress toward reaching their life aims.

Santander selected the FIAT® 500 for the I LOVE MY BANK program for its impressive fuel efficiency, simplicity, quality, and drive for innovation. These are values shared by both brands.

Santander Bank, N.A. is one of the largest retail banks in the United States by deposits. Its main corporate offices are in Boston and it operates principally in Connecticut, Delaware, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania and Rhode Island.

Biogen Idec Inc. (NASDAQ:BIIB)

Today, Biogen Idec Inc. (BIIB), declared data from a pre-specified interim analysis of PRIME, the Phase 1b study of aducanumab (BIIB037), in which aducanumab demonstrated an acceptable safety profile and positive results on radiologic and clinical measurements in patients with prodromal or mild Alzheimer’s disease (AD). These data are being presented recently at the 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders in Nice, France.

Treatment with aducanumab produced a dose- and time-dependent reduction of amyloid plaque in the brain. Amyloid plaque is believed to play a key role in the development of the symptoms of AD. In exploratory analyses, a dose-dependent, statistically noteworthy effect of slowing clinical decline was observed on the Mini Mental State Examination (MMSE) and Clinical Dementia Rating (CDR) scales.

Aducanumab (BIIB037) is an investigational compound being developed for the treatment of Alzheimer’s disease (AD). Aducanumab is a human recombinant monoclonal antibody (mAb) selected from a population of elderly, healthy donors and cognitively stable patients using Neurimmune’s technology platform called Reverse Translational Medicine (RTM). Biogen Idec licensed aducanumab from Neurimmune under a collaborative development and license contract.

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and behavioral disturbances that eventually result in a person’s inability to perform daily activities.

Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology corporation and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally.

Facebook, Inc. (NASDAQ:FB)

Shares of Facebook, Inc. (FB), are hitting an all-time high amid optimism about its advertising business. Jon Steinberg, Daily Mail North America CEO, and Jason Helfstein, Oppenheimer & Co. analyst, talk about.

The social media giant declared recently that it was adding a payment system to its Messenger app, giving users the ability to transfer funds to one another. Smartphone apps that transfer money between users aren’t new, but now that Facebook has entered the market, people are likely to pay more attention.

Facebook shares closed at a record price on Thursday, indicating investor confidence in the corporation’s ability to grow its advertising business.

The record comes after world’s biggest social-networking service stated quarterly proceed and profit in January that topped estimates. The corporation has built out a mobile-advertising business that now accounts for 69 percent of sales, contrast with almost nothing at the time of its 2012 initial public offering.

Facebook, Inc. operates as a social networking corporation worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.

Transocean Ltd. (NYSE:RIG)

Transocean Ltd. (RIG), issued a monthly Fleet Update Summary, which comprises new contracts, changes to existing contracts, and changes in estimated planned out-of-service time of 15 or more days since the February 17, 2015 Fleet Update Summary. The total value of new contracts since the last report is about $9 million.

The report comprises the following:

• Sedco Express - Awarded a one-well contract extension offshore Nigeria at a dayrate of $300,000 ($9 million estimated backlog).
• Henry Goodrich is idle.
• Ultra-deepwater floaters Discoverer Spirit, GSF Jack Ryan, Deepwater Discovery, andDeepwater Pathfinder are stacked. The rigs were formerly idle.
• Estimated 2015 planned out-of-service time reduced by a net 102 days, mainly associated with the Henry Goodrich.

Transocean intends to scrap the Deepwater Expedition, Transocean Legend, Transocean Rather, and GSF Arctic III in an environmentally responsible manner; these rigs are classified as held for sale. As a result, the corporation anticipates its first quarter 2015 results to comprise an estimated non-cash charge of $300 million to $325 million, net of taxes. Counting these four rigs, Transocean has declared plans to scrap a total of 16 floaters.

Transocean is a leading international provider of offshore contract drilling services for oil and gas wells. The corporation specializes in technically demanding sectors of the global offshore drilling business with a particular focus on deepwater and harsh environment drilling services, and believes that it operates one of the most versatile offshore drilling fleets in the world.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.